Inspire Medical Systems Inc

INSP

Equity

ISIN US4577301090 / Valor 41329373

New York Stock Exchange, Inc (2024-11-21)

USD 186.19+0.77%

Inspire Medical Systems Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Inspire Medical Systems Inc. was established in 2007 after the Inspire technology and intellectual property portfolio were spun out of Medtronic. Since its inception, the company has prioritized successful patient outcomes and care experiences, with a motto of putting the patient first to guide its operations. Inspire has made significant investments in the Inspire patient experience reporting (PER) system to continuously improve the patient experience.

Summarized from source with an LLMView SourceSector: Healthcare

Revenue Growth

Inspire Medical Systems Inc. reported a significant year-over-year revenue growth of 30% for the second quarter of 2024. The company generated $195.9 million in revenue, compared to $151.1 million in the same quarter of the previous year. This growth was driven by strong performance in both U.S. and international markets.

Gross Margin

For the second quarter of 2024, Inspire Medical Systems Inc. achieved a gross margin of 84.8%, up from 83.9% in the corresponding period of the prior year. This improvement in gross margin reflects the company's efficient cost management and operational leverage.

Operating Income

Inspire Medical Systems Inc. reported an operating income of $5.1 million for the second quarter of 2024, a significant turnaround from an operating loss of $16.6 million in the same quarter of the previous year. This positive shift underscores the company's improved financial performance and operational efficiency.

Net Income

The company posted a net income of $9.8 million for the second quarter of 2024, compared to a net loss of $12.0 million in the corresponding period of the prior year. The diluted net income per share was $0.32, a notable improvement from a diluted net loss of $0.41 per share in the previous year.

Full Year 2024 Guidance

Inspire Medical Systems Inc. has increased its full year 2024 revenue guidance to between $788 million and $798 million, representing a growth of 26% to 28% over the full year 2023 revenue. Additionally, the company has raised its full year earnings per share guidance to $0.60 to $0.80, up from the previous guidance of $0.10 to $0.20 per share.

Summarized from source with an LLMView Source

Key figures

35.0%1Y

-29.3%3Y

182%5Y

Performance

71.9%1Y

60.4%3Y

60.3%5Y

Volatility